Fraudulent Prescriptions Lead to Conviction in $8.6 Million Medicare Scheme

Key Takeaways

• Fraudulent prescriptions can lead to substantial criminal penalties. The conviction demonstrates how falsified physician orders and medically unnecessary equipment claims can result in federal health care fraud and kickback convictions.
• Improper financial arrangements create legal exposure. The scheme involved illegally purchased prescriptions and payments to medical practitioners, highlighting risks associated with improper referral and prescribing arrangements.
• Prescription verification and medical necessity remain essential. The case underscores the importance of accurate documentation, legitimate prescribing practices, and safeguards against unnecessary medical products being billed to Medicare.

A federal jury in the Middle District of Florida has convicted a Gainesville woman for her involvement in an $8.6 million Medicare fraud scheme involving fraudulent prescriptions for orthotic braces, illegal kickbacks, and the submission of claims for medically unnecessary equipment.

According to the US Department of Justice (DOJ), Sophie Dufort, 57, owned a durable medical equipment (DME) company and managed several other DME companies that participated in a scheme targeting elderly and disabled Medicare beneficiaries. Dufort conspired with Paula Pirone, 70, of Ocala, Florida, and others to submit fraudulent Medicare claims using falsified physician prescriptions.

Fraudulent Prescriptions and Medicare Billing Practices

According to court documents and evidence presented at trial, Dufort and her co-conspirators illegally purchased prescriptions for orthotic braces from purported marketing companies that obtained Medicare beneficiaries' personal information through high-pressure and manipulative telemarketing calls.

The marketing companies subsequently paid medical practitioners to sign prescriptions without contacting or evaluating patients. In other instances, the companies used stolen physician credentials to create forged prescriptions, which were then sold to DME companies operated or managed by Dufort and her co-conspirators.

Evidence presented at trial also revealed instances of falsified telephone recordings used to support fraudulent prescriptions. When questions arose about discrepancies between recorded voices and those of Medicare beneficiaries, a co-conspirator acknowledged that some overseas calls had been fabricated.

The DME companies shipped orthotic braces to Medicare beneficiaries and billed Medicare for the equipment, despite the recipients neither requesting nor medically requiring the devices. According to the DOJ, the fraudulent claims exceeded $8.6 million.

Medical testimony presented during the trial indicated that certain combinations of braces could pose significant safety risks to elderly beneficiaries.

When beneficiaries complained or attempted to return unwanted braces, the defendants instructed them to discard or give away the equipment rather than process returns that would require repayment to Medicare.

Conviction and Potential Penalties

A federal jury convicted Dufort on the following charges:

• Conspiracy to commit health care fraud and wire fraud;
• Two counts of health care fraud;
• Conspiracy to defraud the US and to offer and pay illegal kickbacks; and
• One count of offering and paying illegal kickbacks.

Dufort faces a maximum prison sentence of 20 years for conspiracy to commit health care fraud and wire fraud, 10 years for each health care fraud count and the kickback count, and 5 years for conspiracy to defraud the US and to offer and pay illegal kickbacks.

Sentencing is scheduled for January 2027. A federal district court judge will determine the sentence after considering the US Sentencing Guidelines and other statutory factors.

The case was investigated by the Department of Health and Human Services Office of Inspector General and the Federal Bureau of Investigation.

Implications for Pharmacists and Health Care Providers

The conviction highlights legal and patient safety concerns associated with fraudulent prescribing practices, improper financial arrangements, and Medicare billing for medically unnecessary products.

Although the case involved DME companies rather than pharmacies, it underscores the importance of verifying prescription legitimacy, maintaining appropriate documentation, and ensuring that prescribed products meet patients' medical needs.

For pharmacists and other health care professionals involved in Medicare-reimbursed services, the case also illustrates the potential legal consequences of fraudulent claims and illegal kickback arrangements.

Conclusion

The conviction reinforces federal scrutiny of fraudulent Medicare billing practices involving falsified prescriptions, medically unnecessary equipment, and illegal financial arrangements. The case also emphasizes the importance of prescription integrity, appropriate clinical evaluation, and accountability among health care organizations participating in federal reimbursement programs.

Reference

US Department of Justice. Gainesville woman convicted in $8.6M Medicare fraud scheme. News release. Published October 27, 2026. Accessed October 28, 2026. https://www.justice.gov/opa/pr/gainesville-woman-convicted-86m-medicare-fraud-scheme